AKT1 and melanoma: In detail, E-cadherins are progressively reduced, followed by the concomitant upregulation of N-cadherins, supporting melanoma cells migration, under the control of the phosphoinositide-3-kinase/AKT (PI3K/AKT) pathway 37.